<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="10255">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02973451</url>
  </required_header>
  <id_info>
    <org_study_id>3</org_study_id>
    <nct_id>NCT02973451</nct_id>
  </id_info>
  <brief_title>Laparoscopic Guided Transversus Abdominis Plane Block Versus Trocar Site Infiltration in Gynecologic Laparoscopy.</brief_title>
  <official_title>Laparoscopic Guided Transversus Abdominis Plane Block Versus Trocar Site Infiltration in Gynecologic Laparoscopy.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Zagazig University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Zagazig University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      to compare between Laparoscopic Guided Transversus Abdominis Plane Block and Trocar Site
      Infiltration as postoperative analgesia in Gynecologic Laparoscopic surgery.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      two groups of patients who are eligible for Gynecologic Laparoscopy were randomized to
      either Laparoscopic Guided Transversus Abdominis Plane Block or Trocar Site Infiltration at
      the end of the operation.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>April 2016</start_date>
  <completion_date type="Anticipated">June 2017</completion_date>
  <primary_completion_date type="Anticipated">April 2017</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Participant</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pain Scores</measure>
    <time_frame>24 Hours</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Post Operative Local Anaesthesia</condition>
  <arm_group>
    <arm_group_label>Laparoscopic</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Laparoscopic Guided Transversus Abdominis Plane Block using Bupivacaine</description>
  </arm_group>
  <arm_group>
    <arm_group_label>local</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Trocar Site Infiltration of Bupivacaine</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Laparoscopic Guided Bupivacaine</intervention_name>
    <description>Bupivacaine Laparoscopic GuidedTransversus Abdominis Plane Block</description>
    <arm_group_label>Laparoscopic</arm_group_label>
    <other_name>marcaine</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>local Bupivacaine</intervention_name>
    <description>Bupivacaine Trocar Site Infiltration</description>
    <arm_group_label>local</arm_group_label>
    <other_name>marcaine</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients Need Gynecologic Laparoscopy

        Exclusion Criteria:

          -  Cardiac

          -  Chest disease

          -  Patient refuse participation
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>ibrahim A el sharkwy, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Zagazig University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>ibrahim A EL sharkwy, md</last_name>
    <phone>00966554818576</phone>
    <email>ibrahimsharkwy@yahoo.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>mohamed L el sayeed, md</last_name>
    <phone>00201222442467</phone>
    <email>drmohamedlotfy@yahoo.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Zagazig University</name>
      <address>
        <city>Zagazig</city>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>ibrahim e el sharkwy, md</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>November 2016</verification_date>
  <lastchanged_date>April 3, 2017</lastchanged_date>
  <firstreceived_date>November 22, 2016</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Zagazig University</investigator_affiliation>
    <investigator_full_name>IBRAHIM ABD ELGAFOR</investigator_full_name>
    <investigator_title>assistant professor</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Bupivacaine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
